[Use of lithium oxybutyrate for improving results in the early post-operative period in lung cancer patients].
Application of antihypoxant drugs in postoperative period has been investigated. Lithium oxybutyrate was administered to 30 lung cancer patients before and shortly after operation. The results were compared with the data on 26 patients in control. Major characteristics, and, primarily, its antihypoxic protective effect have been evaluated. Lithium oxybutyrate administration is recommended in lung cancer patients during and shortly after surgery.
Leonenkov
V V
VV
Dunaevskiĭ
I V
IV
Semigolovskiĭ
N I
NI
Barchuk
A S
AS
Evtiukhin
A I
AI
Kostiuchenko
A L
AL
D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D000860:Hypoxia / Q000209:etiology / Q000517:prevention & control*; D008094:Lithium; D008175:Lung Neoplasms / Q000150:complications / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011182:Postoperative Care; D011300:Preoperative Care; D013514:Surgical Procedures, Operative / Q000009:adverse effects
D006885:Hydroxybutyrates; D009942:Organometallic Compounds; C022826:lithium hydroxybutyrate; D008094:Lithium
Primenenie litiia oksibutirata dlia optimizatsii rannego posleoperatsionnogo perioda u bol'nykh rakom legkogo.